Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
47
LXRX Quote, Financials, Valuation and Earnings
Last price:
$1.36
Seasonality move
:
-11.88%
Day range:
$1.14 - $1.33
52-week range:
$0.28 - $2.45
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
14.43x
P/B ratio:
3.81x
Volume:
4.9M
Avg. volume:
4.8M
1-year change:
-42.15%
Market cap:
$468.5M
Revenue:
$31.1M
EPS (TTM):
-$0.51
Earnings Data
Next earnings date for LXRX
Aug 01
2025
Most recent earnings per share
-$0.07
Beat by $0.03
(May 13/2025)
Consensus Estimate
-$0.10
(May 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
LXRX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $4.9M | -- | -- | -$0.08 | -- |
| 08/01/2025 | Q2 | $4.9M | -- | -- | -$0.08 | -- |
| 05/13/2025 | Q1 | $1.2M | $1.3M | -$0.07 | -$0.10 | $0.03 |
| 03/06/2025 | Q4 | $6.5M | $26.6M | -$0.09 | -$0.12 | $0.03 |
| 11/12/2024 | Q3 | $2.9M | $1.8M | -$0.18 | -$0.17 | -$0.01 |
| 08/01/2024 | Q2 | $3.4M | $1.6M | -$0.17 | -$0.19 | $0.02 |
| 05/02/2024 | Q1 | $1.4M | $1.1M | -$0.20 | -$0.20 | -- |
| 03/26/2024 | Q4 | $1.2M | $702K | -$0.20 | -$0.23 | $0.03 |
| 11/08/2023 | Q3 | $2.1M | $162K | -$0.21 | -$0.22 | $0.01 |
| 08/03/2023 | Q2 | $133.3K | $317K | -$0.22 | -$0.17 | -$0.06 |
| 05/02/2023 | Q1 | -- | $24K | -$0.17 | -- | -- |
| 03/02/2023 | Q4 | -- | $28K | -$0.16 | -- | -- |
| 11/09/2022 | Q3 | -- | $39K | -$0.13 | -- | -- |
| 08/02/2022 | Q2 | -- | $35K | -$0.16 | -- | -- |
| 05/05/2022 | Q1 | -- | $37K | -$0.16 | -- | -- |
| 02/28/2022 | Q4 | -- | $14K | -$0.17 | -- | -- |
| 11/03/2021 | Q3 | -- | $23K | -$0.16 | -- | -- |
| 07/30/2021 | Q2 | -- | $234K | -$0.13 | -- | -- |
| 05/06/2021 | Q1 | -- | $27K | -$0.15 | -- | -- |
| 03/10/2021 | Q4 | -- | $199K | -$0.04 | -- | -- |
| 10/29/2020 | Q3 | -- | $6.6M | $0.71 | -- | -- |
| 07/30/2020 | Q2 | -- | $9.2M | -$0.65 | -- | -- |
| 04/27/2020 | Q1 | -- | $8M | -$0.63 | -- | -- |
| 03/12/2020 | Q4 | -- | $8.7M | -$0.48 | -- | -- |
| 11/07/2019 | Q3 | -- | $294.4M | $1.95 | -- | -- |
| 08/01/2019 | Q2 | -- | $9.7M | -$0.22 | -- | -- |
| 05/01/2019 | Q1 | -- | $9.2M | -$0.21 | -- | -- |
| 03/13/2019 | Q4 | -- | $17.1M | -$0.16 | -- | -- |
| 11/01/2018 | Q3 | -- | $7M | -$0.26 | -- | -- |
| 07/30/2018 | Q2 | -- | $13.8M | -$0.33 | -- | -- |
| 05/03/2018 | Q1 | -- | $25.4M | -$0.40 | -- | -- |
| 02/22/2018 | Q4 | -- | $34.4M | -$0.27 | -- | -- |
| 11/08/2017 | Q3 | -- | $26.9M | -$0.29 | -- | -- |
| 08/01/2017 | Q2 | -- | $12.1M | -$0.33 | -- | -- |
| 05/02/2017 | Q1 | -- | $18.3M | -$0.33 | -- | -- |
| 03/03/2017 | Q4 | -- | $19M | -$0.31 | -- | -- |
| 11/01/2016 | Q3 | -- | $27.7M | -$0.35 | -- | -- |
| 08/04/2016 | Q2 | -- | $20.1M | -$0.37 | -- | -- |
| 05/03/2016 | Q1 | -- | $12.5M | -$0.34 | -- | -- |
| 03/01/2016 | Q4 | -- | $127.3M | $0.76 | -- | -- |
| 11/06/2015 | Q3 | -- | $566K | -$0.34 | -- | -- |
Lexicon Pharmaceuticals Earnings Questions
-
How Much did Lexicon Pharmaceuticals Generate in Revenue Last Quarter?
Lexicon Pharmaceuticals reported $1.3M worth of top line sales in its most recent quarter.
-
Did Lexicon Pharmaceuticals Beat Earnings Last Quarter?
Lexicon Pharmaceuticals announced earnings per share of -$0.07 which represents a beat of analyst forecast a -$0.10 per share.
-
Is Lexicon Pharmaceuticals Profitable?
Lexicon Pharmaceuticals reported $1.2M that represents $0.00 per share over the last quarter.
-
What is the Analyst Consensus for Lexicon Pharmaceuticals EPS Next Year?
Lexicon Pharmaceuticals's earnings are forecast to decrease from -$0.63 per share to -$0.69 per share next year representing a decrease of -48.41%.
-
When is Lexicon Pharmaceuticals's Earnings Date?
Lexicon Pharmaceuticals's next earnings date is August 1, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
